NELSON CH - Search Results

1

Function and dysfunction of GEMIN5: understanding a novel neurodevelopmental disorder.

Nelson CH, Pandey UB. Nelson CH, et al. Neural Regen Res. 2024 Nov 1;19(11):2377-2386. doi: 10.4103/NRR.NRR-D-23-01614. Epub 2024 Jan 31. Neural Regen Res. 2024. PMID: 38526274 Free PMC article.

2

Recognizing megatsunamis in Mediterranean deep sea sediments based on the massive deposits of the 365 CE Crete event.

Polonia A, Nelson CH, Vaiani SC, Colizza E, Gasparotto G, Giorgetti G, Bonetti C, Gasperini L. Polonia A, et al. Among authors: nelson ch. Sci Rep. 2022 Mar 28;12(1):5253. doi: 10.1038/s41598-022-09058-3. Sci Rep. 2022. PMID: 35347171 Free PMC article.

3

Semi-Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA.

Meng A, Humeniuk R, Jürgensmeier JM, Hsueh CH, Matzkies F, Grant E, Truong H, Billin AN, Yu H, Feng J, Kwan E, Tarnowski T, Nelson CH. Meng A, et al. Among authors: nelson ch. Clin Pharmacol Ther. 2022 Feb;111(2):416-424. doi: 10.1002/cpt.2439. Epub 2021 Oct 27. Clin Pharmacol Ther. 2022. PMID: 34623640 Free PMC article.

4

Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants.

Anderson K, Nelson CH, Gong Q, Alani M, Tarnowski T, Othman AA. Anderson K, et al. Among authors: nelson ch. Clin Pharmacol Drug Dev. 2022 Feb;11(2):235-245. doi: 10.1002/cpdd.1015. Epub 2021 Sep 1. Clin Pharmacol Drug Dev. 2022. PMID: 34468080 Free PMC article. Clinical Trial.

5

Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects.

Nelson CH, Etchevers K, Yi S, Breckenridge D, Hepner M, Patel U, Ling J, Mathias A. Nelson CH, et al. Clin Pharmacokinet. 2020 Sep;59(9):1109-1117. doi: 10.1007/s40262-020-00878-y. Clin Pharmacokinet. 2020. PMID: 32333325 Clinical Trial.

6

Myasthenic Crisis In Pregnancy.

French DM, Bridges EP, Hoskins MC, Andrews CM, Nelson CH. French DM, et al. Among authors: nelson ch. Clin Pract Cases Emerg Med. 2017 Oct 3;1(4):291-294. doi: 10.5811/cpcem.2017.5.33404. eCollection 2017 Nov. Clin Pract Cases Emerg Med. 2017. PMID: 29849328 Free PMC article.

7

Direct protein-protein interactions and substrate channeling between cellular retinoic acid binding proteins and CYP26B1.

Nelson CH, Peng CC, Lutz JD, Yeung CK, Zelter A, Isoherranen N. Nelson CH, et al. FEBS Lett. 2016 Aug;590(16):2527-35. doi: 10.1002/1873-3468.12303. Epub 2016 Jul 28. FEBS Lett. 2016. PMID: 27416800 Free PMC article.

8

A Quantitative Framework to Evaluate Proarrhythmic Risk in a First-in-Human Study to Support Waiver of a Thorough QT Study.

Nelson CH, Wang L, Fang L, Weng W, Cheng F, Hepner M, Lin J, Garnett C, Ramanathan S. Nelson CH, et al. Clin Pharmacol Ther. 2015 Dec;98(6):630-8. doi: 10.1002/cpt.204. Epub 2015 Sep 29. Clin Pharmacol Ther. 2015. PMID: 26259519 Clinical Trial.

9

Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Nelson CH, Buttrick BR, Isoherranen N. Nelson CH, et al. Curr Top Med Chem. 2013;13(12):1402-28. doi: 10.2174/1568026611313120004. Curr Top Med Chem. 2013. PMID: 23688132 Free PMC article. Review.

10

Puromycin-sensitive aminopeptidase: an antiviral prodrug activating enzyme.

Tehler U, Nelson CH, Peterson LW, Provoda CJ, Hilfinger JM, Lee KD, McKenna CE, Amidon GL. Tehler U, et al. Among authors: nelson ch. Antiviral Res. 2010 Mar;85(3):482-9. doi: 10.1016/j.antiviral.2009.12.003. Epub 2009 Dec 5. Antiviral Res. 2010. PMID: 19969024 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page